Background and Purpose. Lee Silverman Voice Treatment Big (LSVT BIG) is
P
arkinson disease (PD) is a progressive neurodegenerative disorder that affects both motor and nonmotor basal ganglia circuitry. 1 The degeneration of dopaminergic neurons in the substantia nigra leads to the clinical manifestation of the cardinal motor features of PD: bradykinesia, muscle rigidity, tremor at rest, and impairment of postural reflexes. 2 Patients with PD experience increasing difficulties with walking, balance, and bed mobility. Furthermore, they often report clumsiness in activities of daily living (ADL), such as cutting food and tying shoelaces. 3 The effectiveness of physical therapy has been shown in PD, for which a wide range of techniques are used to improve gait, balance, and ADL. 4 Most of these techniques use compensatory movement strategies or external cueing in order to bypass basal ganglia dysfunction. Other treatment protocols focus on retraining the deficient function by repetitive, high-intensity exercises.
The recently developed LSVT BIG treatment, derived from the Lee Silverman Voice Treatment (LSVT), belongs to the latter approaches aiming to restore normal movement amplitude by recalibrating the patient's perception of movement execution. 5, 6 The treatment focuses on intensive exercising of largeamplitude movements. The high intensity of LSVT BIG is predefined by a training mode of 16 individual 1-hour sessions for 4 weeks and an independent home training program. Also, every exercise is repeated at least 8 times and performed with an effort of 80% of the maximal workload. 5 (See video of the therapeutic approach, available at ptjournal.apta.org.) Two studies on the effectiveness of LSVT BIG in people with PD have been reported so far. A randomized trial, including 60 participants, demonstrated improved motor performance after intensive LSVT BIG: cardinal symptoms, such as bradykinesia, hypokinesia, were reduced, as assessed by the motor score on part III of the Unified Parkinson's Disease Rating Scale (UPDRS III). 5 One noncontrolled trial, including 18 participants, showed positive effects on walking speed and reaching movements. 6 However, the effects of LSVT BIG on gait (ie, freezing of gait), balance, bed mobility, and dexterity still remained to be established. 5 All of these factors have been shown to be strongly related to quality of life in individuals with PD 7, 8 ; therefore, improving these functions is important. The aim of the present case series was to examine the potential benefits of LSVT BIG on gait and balance, bed mobility, and dexterity in 3 patients with mild to moderate PD.
Patient History and Systems Review
For this case series, 3 patients were selected who met the following inclusion criteria, based on prior recommendation 6 : idiopathic PD, diagnosed by expert neurologists according to the criteria of the United Kingdom Brain Bank 9 ; Hoehn & Yahr stages I-III, and Mini-Mental State Examination (MMSE) score Ͼ25. The patients did not show any severe depression, disabling dyskinesia, or comorbidity affecting mobility or ability to exercise. Patients 1 and 2 were selected from a neurologist's practice, and patient 3 was selected from a rehabilitation center. All 3 patients were identified by an expert neurologist through diagnosis according to the aforementioned criteria. After an informative consultation between patient and physical therapist, each patient agreed to participate in the 4-week LSVT BIG program. Furthermore, they all signed an informed consent statement. The patients' neurologist was encouraged to keep antiparkinson medications stable unless there was significant worsening of motor function.
The 3 patients described here lived independently in their communities and walked without assistive devices. Patient 1 was diagnosed with PD, with first PD symptoms (tremor of the right hand, rigidity and bradykinetic symptoms also predominantly right-sided) appearing 4 years previously. The previous year, he experienced a slight worsening in body posture and balance. During his daily routine, he further noticed that his slowness of movement and muscle stiffness negatively influenced his piano playing, writing skills, and jogging. While jogging or walking uphill, he often was short of breath. He defined the main goals for his upcoming physical therapy sessions as: (1) to reduce his slow behavior while playing the piano, (2) to improve his writing skills, and (3) to walk uphill with less effort.
Patient 2 was diagnosed with PD 5 years previously. He reported tremor of the right hand, general muscle stiffness, and slowness of movement. He also described some difficulties with writing skills. In addition, while getting in and out of bed, he experienced difficulty (slow and small movements) in turning over left and right in bed. He formulated his personal goals as: (1) to become more mobile again, (2) to improve his mobility when getting in and out of bed, and (3) to be able to drive his car again. His past medical history further revealed chronic low back pain and polyarthritis.
Patient 3 was diagnosed with PD 12 years previously. In addition to his general muscle stiffness and small and slow body movements, he reported a more stooped posture and experienced balance difficulties (incertitude, predominantly during dual tasking). His medical history further revealed carpal tunnel syn-
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drome of both hands, for which he was treated intensively at that time. His personal goals were to improve his body posture, to walk greater distances, to better perform certain dual tasks (eg, standing secured while performing manual tasks), and to achieve better reach toward certain objects and improve their handling. The patients' primary impairments and clinical characteristics identified during the physical examination are specified in Table 1 .
Clinical Impression 1
Based on the described data collected so far, the 3 patients were eligible candidates for the LSVT BIG program. Furthermore, none of the patients revealed a medical history that prevented them from participating in the LSVT BIG program. All patients reported slowness of movement and muscle stiffness, which they experienced as the main reason for their loss of body function and difficulties performing ADL. We hypothesized that the rigidity as well as the bradykinetic and hypokinetic symptoms played an important role in their reported difficulties. Also, all patients reported light to moderate changes in gait, balance, and dexterity skills, which were the main outcomes in this case series. Patient 2 additionally mentioned problems in getting out of bed. Further standardized measurements for gait, balance, dexterity, and bed mobility were needed to objectify reported difficulties before training. These measurements are described in detail in the following section.
Examination
Patients were videotaped while performing all behavioral tests. The performances were rated by an experienced therapist (A.S.), who was blinded with respect to clinical information of the patients. To eliminate possible "on-off" differences, all patients were tested in the on phase, which was about 2 hours after dopaminergic medication intake. Follow-up measurements were taken at the same time point after 4 weeks of LSVT BIG training. All measures were performed within 1 hour.
Gait and Balance Measures
Gait and balance problems are common in individuals with PD, influenced by their change in body posture as well as by bradykinesia, freezing of gait, and dual tasking, 10 often resulting in increased risk for falling. Therefore, multiple tests are recommended in diagnosing gait and balance problems in people with PD. 11 We combined the Functional Gait Assessment (FGA), Functional Reach Test (FRT), Timed "Up & Go" Test (TUG), Freezing of Gait Questionnaire (FOGQ), and the motor score on UPDRS III to ensure a comprehensive evaluation of gait and balance.
The FGA is a 10-item, reliable and valid tool to assess balance during various walking tasks in people with PD. Each item can be scored between 0 and 3 points, with a maximum score of 30 points. A higher total score signifies better balance. 12 A minimal detectable change (MDC) of 4.2 points has been established. 13 To identify high or low risk for falling in people with PD, the use of multiple tests, such as the TUG and FRT, has been recommended. 12 The FRT measures the maximum distance that a person can reach forward with one arm while standing. The mean of 3 reaching trials was used in the current study. It has an MDC of 9 cm for patients with PD. 14 A score below 31.75 cm indicates a high risk for falling. 15 The TUG measures basic walking mobility skills in individuals with mild to moderate PD. 16 On the command "go," the patients were instructed to rise from the chair, walk 3 m at a comfortable and safe pace, turn, walk back to the chair, and sit down. An MDC of 3.5 seconds has been considered to be a true change in PD. 16 A score above 7.95 seconds indicates a high risk for falling. 15 The FOGQ is a valid, selfadministered, 6-item survey instrument designed to assess the severity of freezing of gait in individuals with PD. 17 Each item is rated on a 5-point ordinal scale. The total score ranges from 0 ("absence of symptoms") to 24 ("most severe symptoms"). Until now, no MDC has been established.
The UPDRS III quantifies motor symptoms of PD, reports good testretest reliability, 18 and has an MDC of 5 points. 19 The subscale III contains 14 items, of which each item can be rated between 0 ("normal performance") and 4 ("severe impairment") points.
All patients demonstrated balance problems measured by the FGA (patients 1-3: 27, 25, and 26 points, respectively) and a high risk for falling detected by the FRT (20, 24, and 19 cm, respectively). In addition, patient 2's and patient 3's TUG performance was 11.5 and 7.7 seconds, respectively, further underscoring their risk for falling. All patients demonstrated light to moderate freezing of gait (patients 1-3: 2, 12, and 8 points, respectively, on the FOGQ). Their UPDRS III score was 10, 29, and 34 points, respectively.
Bed Mobility
The Lindop Parkinson's Disease Mobility Assessment (LPA), part B, is a reliable and valid measure of bed mobility in individuals with PD. 20 It measures the time and support needed to perform 4 tasks (sitting to lying down, turning over right and left in bed, and sitting up from a supine position). Each item is scored on a 3-point ordinal scale, where a score of 0 indicates "unable to perform or needing help of 2 people," and a score of 3 indicates "unaided, with ease (in less than 5 seconds)." A total score of 12 indicates no difficulties in bed mobility. Reported difficulties of dexterity skills were confirmed by the results of the 9HPT, in particular for patient 3. We hypothesized that the rigidity as well as bradykinesia and hypokinesia mainly reduced dexterity in both hands. Reported impairments in dexterity were more present on the dominant (right) side for patients 1 and 2. Because LSVT BIG contains exercises, such as spreading out of fingers, we expected improved performance in dexterity skills of both the dominant and nondominant hands.
The LPA did not reveal any deficits in 2 patients, although patient 2 clearly mentioned such difficulties in bed mobility. We hypothesized that his difficulties in bed mobility were related to his bradykinetic and hypokinetic symptoms. Therefore, we expected that after the LSVT BIG intervention, his bed mobility would be performed easier and, consequently, faster.
All patients were determined to be appropriate to participate in the LSVT BIG program due to the presence of bradykinetic and hypokinetic symptoms, which negatively influenced their performance on gait, balance, dexterity and bed mobility.
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Intervention
All participants were engaged in a 4-week training program, supervised by 2 certified LSVT BIG physical therapists (J.J. and K.M. 
Supervised Training (Weeks 1-4)
The supervised training is divided into 3 tasks. Tasks 1 and 2 represent 50% of the exercises and consist of standardized whole-body movements with maximal-amplitude, repetitive, multidirectional movements (eg, stepping and reaching forward, sideward, and backward), and stretching. The other 50% of the exercises are described as task 3, which includes individual goal-directed ADL. Patients received a booklet containing all exercises of tasks 1 and 2. Furthermore, they had a diary that allowed them to document the amount of training sessions and the exercise frequency.
Home Training (Weeks 1-4)
Besides the supervised training, patients were encouraged to do their home training, consisting of repetitions of the supervised training. They trained once a day on days with supervised training and twice a day on days without supervised training. The LSVT BIG program for each patient is described in detail in Table  3 .
Outcomes
Data of outcome measurements were obtained before training started and after 4 weeks of LSVT BIG training. Results of all outcome measures are listed in Table 4 . 
Gait and Balance
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Patient 2, who had most severe freezing of gait before training, showed a striking improvement on the FOGQ. He experienced less freezing of gait. Concerning the UPDRS motor scale, the mean improvement over all 3 patients was 5.6 points, which exceeds the MDC of 5 points. 19 This improvement was most prominent for patients 2 and 3.
Bed Mobility
With respect to bed mobility, 2 patients already had a maximum score of 12 points on the LPA before training. Therefore, no further improvements could be expected on that scale. However, patients 1 and 3 performed the 4 tasks much quicker after LSVT BIG training. Patient 2 demonstrated no more difficulties in sitting up from a supine position and achieved a maximum score of 12 points.
Dexterity
Patients 1 and 3 demonstrated some improvements in dexterity. Although exceeding the MDC, 22 these improvements were only for their nondominant (left) hand. No improvements 
Discussion
Our patients in this case series showed improvements on several outcome measures, including gait, balance, and bed mobility, after 4 weeks of LSVT BIG training. However, the level of improvements differed among the 3 patients and varied on some outcome measurements. These discrepancies may be explained by the fact that the patients described distinct main problems in body functions and activities, also related to their differing stages of PD, although they had in common that they noticed bradykinetic and hypokinetic symptoms, being either mild or moderate. These cardinal motor symptoms typically affected their performance in motor tasks. In line with the Berlin LSVT BIG study, 5 our patients demonstrated similar decreased motor scores on the UPDRS III (mean improvement of 5.6 points), supporting the positive effect of LSVT BIG training on bradykinesia and hypokinesia. These positive changes in motor scores have previously been explained-by focusing on amplitude, movements are expected to be bigger, faster, and more precise. [23] [24] [25] Furthermore, it is known that patients with PD are often unaware of producing small movements and often lack appropriate feedback mechanisms to correct "small" behavior. 5 The LSVT program incorporates feedback mechanisms, such as shaping techniques and, therefore, aims to improve the self-perception of patients with PD, leading them to habitually move with bigger movements. 5 Possible effects from bigger movements on balance, bed mobility, and dexterity skills were not addressed in the previous LSVT BIG studies. 5, 6 Increased FGA scores were found in all patients, suggesting better balance. However, the increment did not exceed the MDC; therefore, the changes cannot be interpreted as a real change. With regard to risk for falling, patients 1 and 3 in this case series demonstrated clinically relevant improvements on the FRT. All 3 patients nearly achieved the normal cutoff score of 31.75 cm after 4 weeks of LSVT BIG training. This finding suggests a reduced risk for falling. However, this explanation is 
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not supported by the performance on the TUG. In all 3 patients, TUG scores did not exceed the MDC, possibly explained by the fact that patients 1 and 3 already had TUG scores indicating low fall risk prior to the intervention. Another explanation could be that the duration of intervention (ie, 4 weeks) was not enough to obtain a clinically relevant change on the TUG, which has been shown previously. 6 Patient 2 experienced less freezing of gait after 4 weeks of LSVT BIG training. This finding may have been due to the combination of specific balance exercises (task 2), which are integrated into the daily routine, possibly stimulating generalization effects, and the focus on largeamplitude movements. However, in contrast to patient 2, the other 2 patients did not show any changes in freezing of gait. This finding suggests that LSVT BIG training does not reduce freezing of gait in all patients with PD, which also has been shown for some patients with PD who received cued gait training. 26 In any case, LSVT BIG training may be an alternative, besides cued gait training, 27 to reduce freezing of gait in some patients with PD.
Another main focus of this case series was to examine possible beneficial effects of LSVT BIG training on bed mobility. We could demonstrate that our 3 patients were quicker performing bed mobility tasks (eg, to sit up from a supine position). These outcomes, however, were not identifiable by the bed mobility subscale of the LPA for patients 1 and 3, possibly due to ceiling effects. Interestingly, patients 1 and 3, who did not train for bed mobility in particular, also benefitted from LSVT BIG training. This finding raises interest in possible effects of LSVT BIG from trained to nontrained tasks.
Finally, possible benefits of LSVT BIG training on dexterity skills also were examined. Our case series demonstrated no improved performance of dexterity skills for the dominant (right) hand in all patients. Furthermore, none of the patients reported improved writing skills. Patients 1 and 3 showed some improvements with their nondominant (left) hand, even exceeding the MDC. These improvements could have been due to spikes in performance of task 2, which consisted of rhythmic exercises, focusing on high-amplitude hand and finger movements. However, patient 2 did not show any benefits of LSVT BIG training on dexterity. We hypothesize that the lack of meaningful improvement can be explained by the fact that LSVT BIG does not specifically stimulate the coordination of small muscle movements, which are imperative for dexterity. Another explanation may be that deficits in dexterity in patients with PD are not only explained by the underlying bradykinesia but also by an apraxic disorder called "limb kinetic apraxia" (LKA). 28 This higher-order motor disorder typically affects dexterity, which is not explained by elementary motor symptoms, and has been suggested to be present in patients with PD. 28 It is clear that our case series limits the ability to generalize our observations to other patients with PD, especially with those in the most advanced stages (ie, IV and V). Furthermore, we did not include a control group, nor did we record any follow-up measurements. Therefore, we do not have information concerning long-lasting effects of LSVT BIG training on gait, balance, bed mobility, and dexterity. Finally, one has to keep in mind that the intensive LSVT BIG program requires a lot of physical effort and adherence from the patients due to its high frequency (16 hours in 4 weeks) and intensity (continuously training with an effort of 80%). Future studies will be needed to explore alternative dosages of LSVT BIG, tailored to physical resources of the patients.
In conclusion, the present case series is the first report describing possible beneficial effects of LSVT BIG training on gait, balance, and bed mobility in patients with mild to moderate PD. Future well-designed, randomized studies will be needed to ascertain the effectiveness and long-term improvements of LSVT BIG training on these functions. 
